Other

Dataset Information

0

Transcriptomic analysis of Diffuse Intrinsic Pontine Glioma (DIPG) identifies a targetable ALDH-positive subset of highly tumorigenic cancer stem-like cells


ABSTRACT: Understanding the cancer stem-cell (CSC) landscape in diffuse intrinsic pontine glioma (DIPG) is desperately needed to address treatment resistance and identify novel therapeutic approaches. Patient derived DIPG cells demonstrated heterogeneous expression of aldehyde dehydrogenase (ALDH) and CD133 by flow cytometry. Transcriptome-level characterization identified elevated mRNA levels of MYC, E2F, DNA damage repair (DDR) genes, glycolytic metabolism and mTOR signaling in ALDH+ compared to ALDH- supporting a stem-like phenotype and indicating a druggable target. ALDH+ cells demonstrated increased proliferation and neurosphere formation and initiated tumors that resulted in decreased survival when orthotopically implanted. Pharmacological MAPK/PI3K/mTOR targeting downregulated MYC, E2F and DDR mRNAs and reduced glycolytic metabolism. In vivo PI3K/mTOR targeting inhibited tumor growth in both flank and an ALDH+ orthotopic tumor model likely by reducing cancer stemness. Characterization of DIPG CSCs coupled with targeting MAPK/PI3K/mTOR signaling provides an impetus for molecularly targeted therapy aimed at addressing the CSC phenotype in DIPG.

ORGANISM(S): Homo sapiens

PROVIDER: GSE149682 | GEO | 2020/11/03

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA256979 | ENA
2013-07-31 | E-GEOD-30669 | biostudies-arrayexpress
2022-01-03 | GSE192899 | GEO
2021-12-31 | GSE192817 | GEO
2012-04-13 | E-GEOD-26621 | biostudies-arrayexpress
2014-09-23 | E-GEOD-59653 | biostudies-arrayexpress
2023-08-30 | GSE211833 | GEO
2016-12-31 | GSE59882 | GEO
2024-09-02 | BIOMD0000000426 | BioModels
2023-08-30 | GSE216180 | GEO